Trials / Completed
CompletedNCT00033839
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Winston Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Civamide (Zucapsaicin) |
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2002-04-12
- Last updated
- 2011-06-10
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00033839. Inclusion in this directory is not an endorsement.